The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning

Hui-Qi Qu, Quan Li, Anne R Rentfro, Susan P Fisher-Hoch, Joseph B McCormick, Hui-Qi Qu, Quan Li, Anne R Rentfro, Susan P Fisher-Hoch, Joseph B McCormick

Abstract

Objective: The lack of standardized reference range for the homeostasis model assessment-estimated insulin resistance (HOMA-IR) index has limited its clinical application. This study defines the reference range of HOMA-IR index in an adult Hispanic population based with machine learning methods.

Methods: This study investigated a Hispanic population of 1854 adults, randomly selected on the basis of 2000 Census tract data in the city of Brownsville, Cameron County. Machine learning methods, support vector machine (SVM) and Bayesian Logistic Regression (BLR), were used to automatically identify measureable variables using standardized values that correlate with HOMA-IR; K-means clustering was then used to classify the individuals by insulin resistance.

Results: Our study showed that the best cutoff of HOMA-IR for identifying those with insulin resistance is 3.80. There are 39.1% individuals in this Hispanic population with HOMA-IR>3.80.

Conclusions: Our results are dramatically different using the popular clinical cutoff of 2.60. The high sensitivity and specificity of HOMA-IR>3.80 for insulin resistance provide a critical fundamental for our further efforts to improve the public health of this Hispanic population.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. The ROC curve for the…
Figure 1. The ROC curve for the identification of the best cutoff value of HOMA-IR.
X-axis represents false positive (FP) rate (or 1-specificity); Y-axis represents true positive (TP) rate (sensitivity).

References

    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419.
    1. Greenfield MS, Doberne L, Kraemer F, Tobey T, Reaven G. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes. 1981;30:387–392.
    1. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487–1495.
    1. Fisher-Hoch SP, Rentfro AR, Salinas JJ, Perez A, Brown HS, et al. Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004–2007. Prev Chronic Dis. 2010;7:A53.
    1. Fan R-E, Chen P-H, Lin C-J. Working Set Selection Using Second Order Information for Training Support Vector Machines. J Mach Learn Res. 2005;6:1889–1918.
    1. Vanni E, Bugianesi E. The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance? Hepatology. 2009;49:1790–1792.
    1. Polyzos SA, Kountouras J, Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med. 2009;9:299–314.
    1. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. The Journal of Clinical Investigation. 2006;116:1793–1801.
    1. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867.
    1. Association AD. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010;33:S62–S69.
    1. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, et al. Diagnosing Insulin Resistance in the General Population. Diabetes Care. 2001;24:460–464.
    1. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, et al. Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism. Diabetes Care. 2003;26:3320–3325.
    1. Hayes MG, Pluzhnikov A, Miyake K, Sun Y, Ng MC, et al. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes. 2007;56:3033–3044.

Source: PubMed

3
订阅